-
1
-
-
0036360546
-
Evolution and spread of antibiotic resistance
-
Normark BH, Normark S. Evolution and spread of antibiotic resistance. J Intern Med 2002; 252:91-106.
-
(2002)
J Intern Med
, vol.252
, pp. 91-106
-
-
Normark, B.H.1
Normark, S.2
-
2
-
-
0035038683
-
Emerging mechanisms of fluoroquinolone resistance
-
Hooper DC. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis 2001; 7:337-41.
-
(2001)
Emerg Infect Dis
, vol.7
, pp. 337-341
-
-
Hooper, D.C.1
-
3
-
-
0033595136
-
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
-
Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med 1999; 341:233-9.
-
(1999)
N Engl J Med
, vol.341
, pp. 233-239
-
-
Chen, D.K.1
McGeer, A.2
de Azavedo, J.C.3
Low, D.E.4
-
4
-
-
0141924871
-
Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections
-
Komp Lindgren P, Karlsson A, Hughes D. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob Agents Chemother 2003; 47: 3222-32.
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 3222-3232
-
-
Komp Lindgren, P.1
Karlsson, A.2
Hughes, D.3
-
5
-
-
25444451566
-
Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: The role of inadequate empirical antibiotic therapy
-
Lautenbach E, Metlay JP, Bilker WB, Edelstein PH, Fishman NO. Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: The role of inadequate empirical antibiotic therapy. Clin Infect Dis 2005; 41:923-9.
-
(2005)
Clin Infect Dis
, vol.41
, pp. 923-929
-
-
Lautenbach, E.1
Metlay, J.P.2
Bilker, W.B.3
Edelstein, P.H.4
Fishman, N.O.5
-
6
-
-
0037035122
-
Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia
-
Davidson R, Cavalcanti R, Brunton JL, et al. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med 2002; 346:747-50.
-
(2002)
N Engl J Med
, vol.346
, pp. 747-750
-
-
Davidson, R.1
Cavalcanti, R.2
Brunton, J.L.3
-
7
-
-
0033864273
-
Mechanisms and spread of fluoroquinolone resistance in Streptococcus pneumoniae
-
Varon E, Gutmann L. Mechanisms and spread of fluoroquinolone resistance in Streptococcus pneumoniae. Res Microbiol 2000; 151:471-3.
-
(2000)
Res Microbiol
, vol.151
, pp. 471-473
-
-
Varon, E.1
Gutmann, L.2
-
8
-
-
4043058319
-
Commensal flora may play key role in spreading antibiotic resistance
-
Andremont A. Commensal flora may play key role in spreading antibiotic resistance. ASM News 2003; 69:601-7.
-
(2003)
ASM News
, vol.69
, pp. 601-607
-
-
Andremont, A.1
-
9
-
-
0031016452
-
Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis
-
Hoiby N, Jarlov JO, Kemp M, et al. Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis. Lancet 1997; 349:167-9.
-
(1997)
Lancet
, vol.349
, pp. 167-169
-
-
Hoiby, N.1
Jarlov, J.O.2
Kemp, M.3
-
11
-
-
0032541786
-
Fluoroquinolone resistance: Overuse of fluoroquinolones in human and veterinary medicine can breed resistance
-
Piddock LJ. Fluoroquinolone resistance: overuse of fluoroquinolones in human and veterinary medicine can breed resistance. BMJ 1998; 317:1029-30.
-
(1998)
BMJ
, vol.317
, pp. 1029-1030
-
-
Piddock, L.J.1
-
12
-
-
0031952586
-
Pharmacokinetic-pharmacodynamic parameters: Rationale for antibacterial dosing in mice and men
-
Craig WA. Pharmacokinetic-pharmacodynamic parameters: rationale for antibacterial dosing in mice and men. Clin Infect Dis 1998; 26: 1-12.
-
(1998)
Clin Infect Dis
, vol.26
, pp. 1-12
-
-
Craig, W.A.1
-
13
-
-
33845696211
-
Pharmacokineticspharmacodynamics of antibiotic therapy: It's not just for mice anymore
-
Ambrose PG, Bhavnani SM, Rubino CM, et al. Pharmacokineticspharmacodynamics of antibiotic therapy: it's not just for mice anymore. Clin Infect Dis 2007; 44:79-86.
-
(2007)
Clin Infect Dis
, vol.44
, pp. 79-86
-
-
Ambrose, P.G.1
Bhavnani, S.M.2
Rubino, C.M.3
-
14
-
-
0035884924
-
Restricting the selection of antibiotic-resistant mutants: A general strategy derived from fluoroquinolone studies
-
Zhao X, Drlica K. Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. Clin Infect Dis 2001; 33(Suppl 3):S147-56.
-
(2001)
Clin Infect Dis
, vol.33
, Issue.SUPPL. 3
-
-
Zhao, X.1
Drlica, K.2
-
15
-
-
0032515386
-
Pharmacodynamics of levofloxacin: A new paradigm for early clinical trials
-
Preston SL, Drusano G, Berman AL, et al. Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials. JAMA 1998; 279: 125-9.
-
(1998)
JAMA
, vol.279
, pp. 125-129
-
-
Preston, S.L.1
Drusano, G.2
Berman, A.L.3
-
16
-
-
0027161344
-
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
-
Forrest A, Nix DE, Ballow CH, Birmingham MC, Cumbo TJ, Schentag JJ. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 1993; 37:1073-81.
-
(1993)
Antimicrob Agents Chemother
, vol.37
, pp. 1073-1081
-
-
Forrest, A.1
Nix, D.E.2
Ballow, C.H.3
Birmingham, M.C.4
Cumbo, T.J.5
Schentag, J.J.6
-
17
-
-
0034812780
-
Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections
-
Ambrose PG, Grasela DM, Grasela TH, Passarel J, Mayer HB, Pierce PF. Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections. Antimicrob Agents Chemother 2001; 45:2793-7.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 2793-2797
-
-
Ambrose, P.G.1
Grasela, D.M.2
Grasela, T.H.3
Passarel, J.4
Mayer, H.B.5
Pierce, P.F.6
-
18
-
-
2442549489
-
Relationship between fluoroquinolone area under the curve: Minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia
-
Drusano G, Preston SL, Fowler C, Corrado M, Weisinger B, Kahn J. Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia. J Infect Dis 2004; 189:1590-7.
-
(2004)
J Infect Dis
, vol.189
, pp. 1590-1597
-
-
Drusano, G.1
Preston, S.L.2
Fowler, C.3
Corrado, M.4
Weisinger, B.5
Kahn, J.6
-
19
-
-
34548265066
-
Optimizing drug exposure to minimize selection of antibiotic resistance
-
Olofsson SK, Cars O. Optimizing drug exposure to minimize selection of antibiotic resistance. Clin Infect Dis 2007; 45:S129-36.
-
(2007)
Clin Infect Dis
, vol.45
-
-
Olofsson, S.K.1
Cars, O.2
-
20
-
-
0038778639
-
Emergence of resistance in normal human aerobic commensal flora during telithromycin and amoxicillin/clavulanic acid treatments
-
Crémieux AC, Muller-Serieys C, Panhard X, et al. Emergence of resistance in normal human aerobic commensal flora during telithromycin and amoxicillin/clavulanic acid treatments. Antimicrob Agents Chemother 2003; 47:2030-5.
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 2030-2035
-
-
Crémieux, A.C.1
Muller-Serieys, C.2
Panhard, X.3
-
21
-
-
84855452587
-
-
Available at:, Accessed 21 June 2009
-
Comité de l'Antibiogramme de la Société Française de Microbiologie. Communiqué 2009. Available at: http://www.sfm.asso.fr/publi/general .php?pa = l. Accessed 21 June 2009.
-
(2009)
Communiqué
-
-
-
22
-
-
0035139520
-
Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae
-
Blondeau JM, Zhao X, Hansen G, Drlica K. Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 2001; 45:433-8.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 433-438
-
-
Blondeau, J.M.1
Zhao, X.2
Hansen, G.3
Drlica, K.4
-
23
-
-
0345550450
-
Update of practice guidelines for the management of communityacquired pneumonia in immunocompetent adults
-
Mandeli LA, Bartlett JG, Dowell SF, File MF Jr, Musher DM, Whitney C. Update of practice guidelines for the management of communityacquired pneumonia in immunocompetent adults. Clin Infect Dis 2003; 37:1405-33.
-
(2003)
Clin Infect Dis
, vol.37
, pp. 1405-1433
-
-
Mandeli, L.A.1
Bartlett, J.G.2
Dowell, S.F.3
File Jr, M.F.4
Musher, D.M.5
Whitney, C.6
-
25
-
-
0028817847
-
Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans
-
Nakashima M, Uematsu T, Kosuge K, et al. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrob Agents Chemother 1995; 39:2635-40.
-
(1995)
Antimicrob Agents Chemother
, vol.39
, pp. 2635-2640
-
-
Nakashima, M.1
Uematsu, T.2
Kosuge, K.3
-
26
-
-
0035180109
-
Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis
-
Montgomery MJ, Beringer PM, Aminimanizani A, et al. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis. Antimicrob Agents Chemother 2001; 45:3468-3473.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 3468-3473
-
-
Montgomery, M.J.1
Beringer, P.M.2
Aminimanizani, A.3
-
27
-
-
0036896404
-
Target site concentrations of ciprofloxacin after single intravenous and oral doses
-
Brunner M, Stabeta H, Moller JG, et al. Target site concentrations of ciprofloxacin after single intravenous and oral doses. Antimicrob Agents Chemother 2002; 46:3724-30.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 3724-3730
-
-
Brunner, M.1
Stabeta, H.2
Moller, J.G.3
-
28
-
-
0036239477
-
Pharmacokinetic parameters of ciprofloxacin (500 mg/5 mL) oral suspension in critically ill patients with severe bacterial pneumonia: A comparison of two dosages
-
Debon R, Breilh D, Boselli E, et al. Pharmacokinetic parameters of ciprofloxacin (500 mg/5 mL) oral suspension in critically ill patients with severe bacterial pneumonia: a comparison of two dosages. J Chemother 2002; 14:175-80.
-
(2002)
J Chemother
, vol.14
, pp. 175-180
-
-
Debon, R.1
Breilh, D.2
Boselli, E.3
-
29
-
-
0030067792
-
Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis
-
Carratala J, Fernandez-Sevilla A, Tubau F, Domínguez MA, Gudiol F. Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrob Agents Chemother 1996; 40:503-5.
-
(1996)
Antimicrob Agents Chemother
, vol.40
, pp. 503-505
-
-
Carratala, J.1
Fernandez-Sevilla, A.2
Tubau, F.3
Domínguez, M.A.4
Gudiol, F.5
-
30
-
-
0032837575
-
Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis
-
Perea S, Hidalgo M, Arcediano A, et al. Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis. J Antimicrob Chemother 1999; 44:117-20.
-
(1999)
J Antimicrob Chemother
, vol.44
, pp. 117-120
-
-
Perea, S.1
Hidalgo, M.2
Arcediano, A.3
-
31
-
-
0028121079
-
Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis
-
Dupeyron C, Mangeney N, Sedrati L, Campillo B, Fouet P, Leluan G. Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis. Antimicrob Agents Chemother 1994; 38:340-4.
-
(1994)
Antimicrob Agents Chemother
, vol.38
, pp. 340-344
-
-
Dupeyron, C.1
Mangeney, N.2
Sedrati, L.3
Campillo, B.4
Fouet, P.5
Leluan, G.6
-
32
-
-
0031940776
-
Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy
-
Thomas JK, Forrest A, Bhavnani SM, et al. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother 1998; 42:521-7.
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 521-527
-
-
Thomas, J.K.1
Forrest, A.2
Bhavnani, S.M.3
-
33
-
-
0035468838
-
Effect of antibiotic agents on the ecological balance of human microflora
-
Sullivan A, Edlund C, Nord CE. Effect of antibiotic agents on the ecological balance of human microflora. Lancet Infect Dis 2001; 1:101-14.
-
(2001)
Lancet Infect Dis
, vol.1
, pp. 101-114
-
-
Sullivan, A.1
Edlund, C.2
Nord, C.E.3
-
34
-
-
0025123303
-
Faecal excretion of ciprofloxacin after a single oral dose and its effect on faecal bacteria in healthy volunteers
-
Pecquet S, Ravoire S, Andremont A. Faecal excretion of ciprofloxacin after a single oral dose and its effect on faecal bacteria in healthy volunteers. J Antimicrob Chemother 1990; 26:125-9.
-
(1990)
J Antimicrob Chemother
, vol.26
, pp. 125-129
-
-
Pecquet, S.1
Ravoire, S.2
Andremont, A.3
-
35
-
-
33745920513
-
Antibiotic stress induces genetic transformability in the human pathogen Streptococcus pneumoniae
-
Prudhomme M, Attaiech L, Sanchez G, Martin B, Claverys JP. Antibiotic stress induces genetic transformability in the human pathogen Streptococcus pneumoniae. Science 2006; 313:89-92.
-
(2006)
Science
, vol.313
, pp. 89-92
-
-
Prudhomme, M.1
Attaiech, L.2
Sanchez, G.3
Martin, B.4
Claverys, J.P.5
|